Introduction
It is with great pleasure that we announce that Current Therapeutic Research is now indexed on PubMed and that all articles in the back catalog have been fully uploaded to the system. This is a major step forward in improving the visibility of articles accepted by the journal, which increases the attractiveness of the journal for authors.
In addition, we have decreased the time from submission to first decision to 21 days. Furthermore, we are continuing our significantly reduced payment for open access through 2015. Consider submitting your research to the journal to benefit from a very quick turnaround time, reduced fees, and immediate access to your article on PubMed.
What are we are looking for?
The journal features articles in the area of clinical therapeutic research, which generally focuses on adults, but we encourage authors to submit work in the additional research areas of pregnant women, newborn infants, children, and adolescents. Indeed, we not only want to see studies in these areas with positive results, but also those with negative results.
Moreover, we encourage research manuscripts in the areas of clinical pharmacology, pharmacoepidemiology, and pharmacovigilance in adults-specifically in special populations such as geriatric patients and pregnant women-and children of all ages. We are very receptive to research that uses national or international databases to detect drug-drug interactions and age-specific serious adverse drug events. Issues related to developing and applying age-appropriate formulations in children and geriatric patients are also welcome. Pharmacokinetics studies and those exploring pharmacodynamics will also be enthusiastically reviewed and considered for publication.
The reporting of peer-reviewed results of original research and well-designed reviews is the bedrock of the dissemination and advancement of science. This is a responsibility that your Editorial Team takes very seriously. Although publishing is sometimes considered a 1-way conversation, it is in fact a dialogue among all stakeholders that leads to improved journal articles, science, and progress. Technology has eased the flow of communication. Questions for the Editorial Team are welcome.
